Nanotechnology
Research from Johns Hopkins University Has Provided New Data on Nanotechnology
Published in Gene Therapy Weekly, February 17th, 2011
2011 FEB 17 -- According to a study from the United States, "The ability to destroy cancer cells while sparing normal tissue is highly sought after in cancer therapy small interfering RNA (SiRNA) mediated silencing of cancer cell specific targets and the use of a prodrug enzyme delivered to the tumor to convert a nontoxic prodrug to an active drug approaches are two promising approaches in achieving this goal Combining both approaches into a single treatment strategy can amplify selective targeting of cancer cells while sparing normal tissue."
"Non invasive imaging can assist in optimizing such a strategy by determining effective tumor delivery of the siRNA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-02-17)
More Articles from Gene Therapy Weekly
- Gene Therapy
Findings from University Medical Center, Division of Medical Genetics Provide New Insights into Gene Therapy - Small Interference RNAs (siRNAs)
Findings from Veterans Affairs Medical Center Advance Knowledge in Small Interference RNAs (siRNAs) - Gene Therapy
Findings in Gene Therapy Reported from R. Girod and Co-Researchers - MedAssets
Hollywood Presbyterian Medical Center Selects MedAssets for Comprehensive Revenue Cycle Services to Drive Financial Performance - Cancer Therapy
New Cancer Therapy Research from University of Minnesota, Department of Surgery Discussed - Stem Cell Research
New Findings Reported from Baylor College of Medicine, Department of Pediatrics Describe Advances in Stem Cell Research - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
